Controlling deamidation rates in a model peptide: Effects of temperature, peptide concentration, and additives

被引:49
作者
Stratton, LP
Kelly, RM
Rowe, J
Shively, JE
Smith, DD
Carpenter, JF
Manning, MC
机构
[1] Univ Colorado, Hlth Sci Ctr, Ctr Pharmaceut Biotechnol, Denver, CO 80262 USA
[2] Univ Colorado, Hlth Sci Ctr, Sch Pharm, Dept Pharmaceut Sci, Denver, CO 80262 USA
[3] Creighton Univ, Sch Med, Dept Biomed Sci, Omaha, NE 68178 USA
[4] Furman Univ, Dept Biol, Greenville, SC 29613 USA
关键词
deamidation; poloxamer; gel; peptide stability; Arrhenius plot;
D O I
10.1002/jps.1165
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The rate of deamidation of the Asn residue in Val-Tyr-Pro-Asn-Gly-Ala (VYPNGA), a model peptide, was determined at pH 9 (400 mM Tris buffer) as a function of temperature and peptide concentration. Over the temperature range 5-65 degreesC, deamidation followed Arrhenius behavior, with an apparent activation energy of 13.3 kcal/mol. Furthermore, increasing the peptide concentration slows the rate of deamidation. Self-stabilization with respect to deamidation has not been reported previously. The rate of deamidation was also determined in the presence of sucrose and poloxamer 407 (Pluronic F127). In both cases, the rate of deamidation was retarded by up to 40% at 35 degreesC. In aqueous solutions containing poloxamer 407, the degree of stabilization is independent of formation of a reversible thermosetting gel. With sucrose, maximum reduction in the deamidation rate was attained with as little as 5% (w/v). Addition of sucrose results in a greater conformational preference for a type II beta -turn structure, which presumably is less prone to intramolecular cyclization and subsequent deamidation. (C) 2001 Wiley-Liss, Inc. and the American Pharmaceutical Association.
引用
收藏
页码:2141 / 2148
页数:8
相关论文
共 31 条
[1]   SEQUENCE-SPECIFIC DEAMIDATION - ISOLATION AND BIOCHEMICAL-CHARACTERIZATION OF SUCCINIMIDE INTERMEDIATES OF RECOMBINANT HIRUDIN [J].
BISCHOFF, R ;
LEPAGE, P ;
JAQUINOD, M ;
CAUET, G ;
ACKERKLEIN, M ;
CLESSE, D ;
LAPORTE, M ;
BAYOL, A ;
VANDORSSELAER, A ;
ROITSCH, C .
BIOCHEMISTRY, 1993, 32 (02) :725-734
[2]  
BRENNAN TV, 1993, PROTEIN SCI, V2, P331
[3]  
Brennan TV, 1995, DEAMIDATION ISOASPAR
[4]  
BRENNAN TV, 1993, J BIOL CHEM, V269, P25486
[5]   Development of a stable freeze-dried formulation of recombinant human interleukin-1 receptor antagonist [J].
Chang, BS ;
Reeder, G ;
Carpenter, JF .
PHARMACEUTICAL RESEARCH, 1996, 13 (02) :243-249
[6]   PROPENSITY FOR SPONTANEOUS SUCCINIMIDE FORMATION FROM ASPARTYL AND ASPARAGINYL RESIDUES IN CELLULAR PROTEINS [J].
CLARKE, S .
INTERNATIONAL JOURNAL OF PEPTIDE AND PROTEIN RESEARCH, 1987, 30 (06) :808-821
[7]   The excluding effects of sucrose on a protein chemical degradation pathway: Methionine oxidation in subtilisin [J].
DePaz, RA ;
Barnett, CC ;
Dale, DA ;
Carpenter, JF ;
Gaertner, AL ;
Randolph, TW .
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 2000, 384 (01) :123-132
[8]  
GEIGER T, 1987, J BIOL CHEM, V262, P785
[9]   A transient expansion of the native state precedes aggregation of recombinant human interferon-γ [J].
Kendrick, BS ;
Carpenter, JF ;
Cleland, JL ;
Randolph, TW .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (24) :14142-14146
[10]   Preferential exclusion of sucrose from recombinant interleukin-1 receptor antagonist: Role in restricted conformational mobility and compaction of native state [J].
Kendrick, BS ;
Chang, BS ;
Arakawa, T ;
Peterson, B ;
Randolph, TW ;
Manning, MC ;
Carpenter, JF .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (22) :11917-11922